Interferon alpha induces cell death through interference with interleukin 6 signaling and inhibition of STAT3

Lena Thyrell1, Velmurugesan Arulampalam, Linn Hjortsberg

  • 1Department of Oncology and Pathology, Cancer Center Karolinska, Karolinska Hospital and Institute, S-171 76 Stockholm, Sweden.

Experimental Cell Research
|September 21, 2007
PubMed

Insights

Interferon alpha (IFNalpha) inhibits STAT3 signaling, a key survival pathway in multiple myeloma. This inhibition leads to apoptosis in myeloma cells, offering a potential therapeutic strategy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunology

Background:

  • Multiple myeloma survival often relies on interleukin 6 (IL-6) signaling.
  • IL-6 survival signaling is primarily mediated by Signal Transducer and Activator of Transcription 3 (STAT3) activation.
  • Interferon alpha (IFNalpha) induces apoptosis in multiple myeloma cells.

Purpose of the Study:

  • To investigate the mechanism by which IFNalpha induces apoptosis in multiple myeloma cells.
  • To determine the role of STAT3 signaling in IFNalpha-mediated apoptosis.
  • To explore the interaction between IFNalpha and IL-6/STAT3 pathways in myeloma.

Main Methods:

  • Treatment of multiple myeloma cell lines (U266-1984, U-1958) with IFNalpha.
  • Electrophoretic Mobility Shift Assay (EMSA) to assess STAT3 DNA-binding activity.
  • Analysis of STAT3 target gene expression (Bcl-X(L), Mcl-1, survivin).
  • Ectopic expression of a constitutively active STAT3 mutant (STAT3C).

Main Results:

  • IFNalpha treatment decreased STAT3 DNA-binding activity and shifted STAT complexes from STAT3/3 to STAT1/1 and STAT3/1.
  • This led to down-regulation of STAT3 target genes like Bcl-X(L), Mcl-1, and survivin.
  • Ectopic expression of STAT3C rescued cells from IFNalpha-induced apoptosis, promoting sustained STAT3 activity and up-regulation of Bcl-2 and Mcl-1.

Conclusions:

  • IFNalpha interferes with IL-6 signaling by inhibiting STAT3 activity in multiple myeloma cells.
  • The abrogation of STAT3 activity by IFNalpha is crucial for inducing apoptosis in myeloma.
  • Targeting STAT3 signaling with IFNalpha presents a potential therapeutic approach for multiple myeloma.

Related Concept Videos

Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Cellular Injury IlI: Cellular Death01:11

Cellular Injury IlI: Cellular Death

Cell death is the irreversible loss of cellular structure and function, representing the final stage of severe injury. It plays a key role in both normal physiology and disease.Types of Cell DeathThe two main types are necrosis and apoptosis, though others like necroptosis and pyroptosis also exist.Necrosis:Necrosis is an unregulated form of cell death caused by severe injury such as trauma, toxins, or ischemia. It is characterized by cell swelling, membrane loss, rupture, and leakage of...